Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001104659-18-042302
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-26 16:47:53
Reporting Period:
2018-06-25
Accepted Time:
2018-06-26 16:47:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1674365 Aptinyx Inc. APTX Pharmaceutical Preparations (2834) 474626057
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1741606 R. Joseph Moskal C/o Aptinyx Inc.
909 Davis Street, Suite 600
Evanston IL 60201
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-25 8,464 $0.00 359,063 No 4 C Direct
Common Stock Acquisiton 2018-06-25 9,673 $0.00 368,736 No 4 C Direct
Common Stock Acquisiton 2018-06-25 6,552 $0.00 375,288 No 4 C Direct
Common Stock Acquisiton 2018-06-25 3,000 $16.00 378,288 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Direct
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A-1 Convertible Preferred Stock Disposition 2018-06-25 233,496 $0.00 8,464 $0.00
Common Stock Series A-2 Convertible Preferred Stock Disposition 2018-06-25 266,851 $0.00 9,673 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2018-06-25 180,734 $0.00 6,552 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
Footnotes
  1. Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.
  2. On June 25, 2018, the Reporting Person purchased 3,000 shares of common stock of the Issuer at a price of $16.00 per share pursuant to an underwritten public offering.